Table 7. Percentage of patients that achieve the 62-day target (current pathway).
| Treatment path | Baseline | Outpatients within 7 days | 7 days between tests | 3 days between tests | 1 day between tests | Tests reported within 2 days | Tests reported within 1 day | Outpatients within 7 days, 3 days between tests and reported within 2 days | Outpatients within 7 days, 1 day between tests and next-day report |
|---|---|---|---|---|---|---|---|---|---|
| SACT (RGH) | 69.84 (68.56–71.12) | 81.99 (80.73–83.25) | 70.92 (69.64–72.21) | 80.04 (78.73–81.34) | 83.19 (81.93–84.44) | 78.64 (77.34–79.94) | 79.80 (78.52–81.08) | 87.06 (85.85–88.27) | 90.26 (89.15–91.38) |
| Radiotherapy (RGH) | 79.98(79.14–80.82) | 91.61 (91.08–92.13) | 81.85 (81.03–82.68) | 89.60 (88.96–90.24) | 92.83 (92.33–93.33) | 89.13 (88.48–89.78) | 89.70 (89.10–90.31) | 95.60 (95.20–96.00) | 97.16 (96.82–97.50) |
| Surgery (RGH) | 50.75 (49.22–52.28) | 63.01 (61.34–64.68) | 51.97 (50.46–53.49) | 60.62 (58.93–62.31) | 63.88 (62.19–65.56) | 58.66 (57.03–60.30) | 60.57 (58.92–62.22) | 67.81 (66.09–69.53) | 72.44 (70.74–74.13) |
| SACT (PCH) | 61.94 (60.92–62.95) | 77.87 (76.88–78.86) | 68.46 (67.40–69.51) | 74.86 (73.83–75.90) | 79.39 (78.39–80.40) | 72.64 (71.61–73.68) | 74.05 (73.04–75.06) | 85.61 (84.66–86.55) | 88.09 (87.18–88.99) |
| Radiotherapy (PCH) | 65.48 (64.78–66.18) | 82.31 (81.65–82.98) | 72.98 (72.27–73.69) | 79.73 (79.04–80.42) | 83.49 (82.83–84.14) | 76.52 (75.85–77.20) | 78.59 (77.93–79.25) | 89.50 (88.92–90.07) | 91.74 (91.23–92.25) |
| Surgery (PCH) | 41.38 (40.13–42.62) | 54.23 (52.74–55.72) | 44.92 (43.57–46.27) | 50.95 (49.49–52.42) | 54.46 (52.95–55.97) | 49.22 (47.83–50.60) | 51.10 (49.69–52.51) | 60.51 (58.90–62.13) | 64.10 (62.47–65.73) |
SACT, systemic anti-cancer treatment; RGH, Royal Glamorgan Hospital; PCH, Prince Charles Hospital.